Clinical Trial Update: Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumour Patients [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety and preliminary efficacy of BAT6026 in patients with advanced solid tumors; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• BAT6026

Snippet

Sponsor: Bio-Thera Solutions | Conditions: Advanced Solid Tumour | Phase 1 | Status: TERMINATED